Rockwell Medical, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.5M | 138 | 72.3% |
| Consulting Fee | $556,893 | 172 | 26.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $13,468 | 4 | 0.6% |
| Travel and Lodging | $7,356 | 27 | 0.4% |
| Food and Beverage | $3,278 | 133 | 0.2% |
| Education | $250.80 | 19 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Equivalence Of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate And Intravenously To Adult Ckd-5hd Patients | $394,218 | 0 | 11 |
| Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis | $298,196 | 0 | 14 |
| RMFPC 26 | $233,380 | 0 | 21 |
| RMFPC 24 | $133,568 | 0 | 5 |
| Hemoglobin Maintenance in Pediatric ESRD Patients by Ferric Pyrophosphate Citrate (FPC) | $127,484 | 0 | 31 |
| Triferic Pediatric Pharmacokinetic Protocol | $61,321 | 0 | 17 |
| Equivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients | $53,233 | 0 | 2 |
| The Pursuit of a More Physologic Iron and ESA Treatment Triferic and Individualized Web-Based ESA Protocol QA Project | $48,225 | 0 | 1 |
| Triferic IRIDA Protocol | $36,759 | 1 | 8 |
| Triferic (Ferric Pyrophosphate Citrate) Administered Orally with Shohls Solution for the Treatment of Iron-Refractory Iron-Deficiency Anemia | $33,072 | 1 | 6 |
| RMFPC-25 | $29,512 | 0 | 4 |
| Heparin | $22,927 | 1 | 1 |
| Heparin Study | $19,737 | 1 | 1 |
| RM Heparin Study | $6,317 | 1 | 2 |
| Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally with Shohl's Solution in Healthy Volunteers | $6,000 | 1 | 4 |
| Triferic Pediatric Trial | $4,825 | 0 | 1 |
| Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered via Hemodialysate and Intravenously to Adult CKD-5HD Patients | $3,779 | 0 | 2 |
| Single Ascending Dose Study of Intraperitoneal Triferic (Ferric Pyrophosphate Citrate) in Patients on Chronic Peritoneal Dialysis | $1,200 | 0 | 6 |
| RMC-26 | $1,155 | 0 | 1 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Nephrology | $396,365 | 91 | $4,356 |
| Cardiovascular Disease | $25,458 | 3 | $8,486 |
| Specialist | $16,491 | 6 | $2,748 |
| Internal Medicine | $12,412 | 27 | $459.69 |
| Gastroenterology | $12,016 | 2 | $6,008 |
| Pulmonary Disease | $4,300 | 1 | $4,300 |
| Thoracic Surgery (Cardiothoracic Vascular Surgery) | $3,000 | 1 | $3,000 |
| Adult Health | $2,158 | 2 | $1,079 |
| Medical Genetics, Ph.D. Medical Genetics | $92.20 | 1 | $92.20 |
| Orthopaedic Surgery | $66.67 | 1 | $66.67 |
| Family Medicine | $60.60 | 1 | $60.60 |
| Hospitalist | $32.36 | 2 | $16.18 |
| Student in an Organized Health Care Education/Training Program | $20.53 | 1 | $20.53 |
| Nurse Practitioner | $19.70 | 1 | $19.70 |
| Infectious Disease | $16.45 | 1 | $16.45 |
| Ophthalmology | $16.45 | 1 | $16.45 |
| Pediatric Nephrology | $16.45 | 1 | $16.45 |
| Family | $16.12 | 1 | $16.12 |
| Anesthesiologist Assistant | $11.29 | 1 | $11.29 |
| General Acute Care Hospital | $11.29 | 1 | $11.29 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2020 |
|---|---|---|---|---|
| Unknown Provider | — | — | $201,023 | $0 |
| Allen Nissenson, Md, MD | Nephrology | Los Angeles, CA | $101,367 | $0 |
| Anatole Besarab, M.d, M.D | Nephrology | Detroit, MI | $90,484 | $0 |
| Dr. Thomas Marbury, M.d, M.D | Nephrology | Orlando, FL | $48,981 | $0 |
| Jay Wish, Md, MD | Nephrology | Indianapolis, IN | $26,614 | $0 |
| Dr. Michael Germain, Md, MD | Nephrology | Springfield, MA | $24,342 | $0 |
| Dr. Marcos Rothstein, Md, MD | Nephrology | Saint Louis, MO | $21,856 | $0 |
| Dr. Robert Provenzano, Md, MD | Nephrology | Portland, OR | $16,800 | $0 |
| Dr. Inderjit Anand, Md, Frcp, D Phil, Fa, MD, FRCP, D PHIL, FA | Cardiovascular Disease | Minneapolis, MN | $12,458 | $0 |
| Mark Delegge, Md, MD | Gastroenterology | Charleston, SC | $12,000 | $0 |
| Lance Sloan, Md, MD | Nephrology | Lufkin, TX | $11,736 | $0 |
| Jonathan Plehn, M.d, M.D | Cardiovascular Disease | Philadelphia, PA | $10,000 | $0 |
| Steven Fishbane, M.d, M.D | Specialist | Mineola, NY | $8,548 | $0 |
| Abdul Abdellatif, M.d, M.D | Internal Medicine | Webster, TX | $8,408 | $0 |
| Unknown Provider | — | — | $6,800 | $0 |
| John Wigneswaran, Md, MD | Nephrology | Dayton, OH | $6,150 | $0 |
| Dr. Daniel Coyne, Md, MD | Nephrology | Saint Louis, MO | $5,475 | $0 |
| George Aronoff, Md, MD | Nephrology | Louisville, KY | $5,051 | $0 |
| Dr. John Daugirdas, Md, MD | Nephrology | Burr Ridge, IL | $4,575 | $0 |
| Naveed Masani, M.d, M.D | Specialist | Mineola, NY | $4,488 | $0 |
| Tomas Ganz, Md, MD | Pulmonary Disease | Los Angeles, CA | $4,300 | $0 |
| Csaba Kovesdy, M.d, M.D | Nephrology | Salem, VA | $3,675 | $0 |
| Dr. Edward Himot, M.d, M.D | Specialist | Marietta, GA | $3,383 | $0 |
| Dr. Beckie Michael, Do, DO | Internal Medicine | Marlton, NJ | $3,357 | $0 |
| Nicole Stankus | Nephrology | Chicago, IL | $3,354 | $0 |
About Rockwell Medical, Inc.
Rockwell Medical, Inc. has made $2.1M in payments to 150 healthcare providers, recorded across 493 transactions in the CMS Open Payments database. In 2022, the company paid $5,208. The top product by payment volume is TRIFERIC ($903,094).
Payments were distributed across 20 medical specialties. The top specialty by payment amount is Nephrology ($396,365 to 91 doctors).
Payment categories include: Food & Beverage ($3,278), Consulting ($556,893), Research ($1.5M), Travel & Lodging ($7,356).
Rockwell Medical, Inc. is associated with 2 products in the CMS Open Payments database.